A single-arm study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in Japanese healthy adults

jiie Mugen0 个研究点目标入组 50 人开始时间: 2022年6月30日最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•1) Persons who have given written consent to participate in the research in person.
•2) Men and women who are at least 20 year of age at the time consent is obtained
•3) Persons who are expected to work for patients with monkeypox in National Center of Global Health and Medicine
•4) Persons who have developed neither monkeypox nor smallpox.

•1) Persons with diseases that are clearly abnormalin immune function
•2) Persons using corticosteroids or immunosuppressive drugs (cyclosporine, tacrolimus, azathioprine, biological drugs)
•3) Persons with an apparent history of anaphylaxiscaused by components of the smallpox vaccine
•4) Patients with apparent fever
•5) Persons who are obviously suffering from a serious acute disease
•6) Those who are obviously pregnant
•7) Persons suffering from a spreading skin disease,which may be impaired by immunization.
•8) Persons who are in an inappropriate condition to be immunized.
•9) Persons who are judged by the principal investigator to be inappropriate for inclusion in the study.

发起方

jiie Mugen